Division of Hospital Medicine, Department of Medicine, Denver Health, 777 Bannock Street, Denver, CO, 80204, USA.
Division of Hospital Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
J Gen Intern Med. 2023 Aug;38(11):2560-2567. doi: 10.1007/s11606-022-08014-1. Epub 2023 Jan 25.
Individuals prescribed long-term opioid therapy (LTOT) have increased risk of readmission and death after hospital discharge. The risk of opioid overdose during the immediate post-discharge time period is unknown.
To examine the association between time since hospital discharge and opioid overdose among individuals prescribed LTOT.
Self-controlled risk interval analysis.
Adults prescribed LTOT with at least one hospital discharge at a safety-net health system and a non-profit healthcare organization in Colorado.
We identified individuals prescribed LTOT who were discharged from January 2006 through June 2019. The outcome was a composite of fatal and non-fatal opioid overdoses during a 90-day post-discharge observation period, identified using electronic health record (EHR) and vital statistics data. Risk intervals included days 0-6 after index and subsequent hospital discharges. Control intervals ranged from days 7 to 89 after index discharge and included all other time during the observation period that did not fall within a risk interval or time readmitted during a subsequent hospitalization, which was excluded. Poisson regression was used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI) for overdose events during risk in comparison to control intervals.
We identified 7695 adults (63.3% over 55 years, 59.4% female, 20.3% Hispanic) who experienced 9499 total discharges during the study period. Twenty-one overdoses occurred during their observation periods (1174 per 100,000 person-years [9 in risk, 12 in control]). Overdose risk was significantly higher during the risk interval in comparison to the control interval (IRR 6.92; 95% CI 2.92-16.43).
During the first 7 days after hospital discharge, individuals prescribed LTOT appear to be at elevated risk for opioid overdose. Clarifying mechanisms of overdose risk may help inform in-hospital and post-discharge prevention strategies.
长期接受阿片类药物治疗(LTOT)的患者在出院后再次入院和死亡的风险增加。出院后即刻发生阿片类药物过量的风险尚不清楚。
研究 LTOT 患者出院时间与阿片类药物过量之间的关系。
自我对照风险间隔分析。
在科罗拉多州的一家医疗保障体系和非营利性医疗机构接受 LTOT 治疗的成年人,至少有一次出院记录。
我们确定了 2006 年 1 月至 2019 年 6 月期间出院的 LTOT 患者。该研究的结果是出院后 90 天观察期内致命和非致命阿片类药物过量的复合指标,该指标通过电子健康记录(EHR)和生命统计数据确定。风险间隔包括出院后第 0-6 天和随后的医院出院。对照间隔范围从出院后第 7 天到第 89 天,包括观察期内不属于风险间隔或随后住院期间再次入院的所有其他时间,这些时间均被排除在外。使用泊松回归估计风险间隔与对照间隔相比,过量事件的发生率比(IRR)和 95%置信区间(CI)。
我们确定了 7695 名成年人(55 岁以上占 63.3%,女性占 59.4%,西班牙裔占 20.3%),他们在研究期间经历了 9499 次总出院。在观察期间发生了 21 例过量事件(每 100000 人年发生 1174 例[风险中 9 例,对照中 12 例])。与对照间隔相比,风险间隔期间的过量风险显著升高(IRR 6.92;95%CI 2.92-16.43)。
出院后 7 天内,LTOT 患者似乎面临更高的阿片类药物过量风险。阐明过量风险的机制可能有助于制定住院和出院后预防策略。